🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
ZVR
$ZVRA
🔒 US EquitiesZevra Therapeutics Inc
AVG HISTORICAL GAP
-1.08%
MAX GAP RECORD
+20.07%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $ZVRA
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$ZVRA
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 05, 2026 Earnings Release 2026-08-05 (AFTER CLOSE) |
+7.36%
|
| May 06, 2026 Earnings Release 2026-05-06 (AFTER CLOSE) |
-3.47%
|
| Mar 09, 2026 Earnings Release 2026-03-09 (AFTER CLOSE) |
+20.07%
|
| Nov 05, 2025 Earnings Release 2025-11-05 (AFTER CLOSE) |
-5.66%
|
| Aug 12, 2025 Earnings Release 2025-08-12 (AFTER CLOSE) |
-12.07%
|
| May 13, 2025 Earnings Release 2025-05-13 (AFTER CLOSE) |
+8.01%
|
| Mar 11, 2025 Earnings Release 2025-03-11 (AFTER CLOSE) |
-0.62%
|
| Nov 12, 2024 Earnings Release 2024-11-12 (AFTER CLOSE) |
-5.72%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
6.3%
Bullish Gaps (3)
Bearish Gaps (9)
Neutral / Flat (2)
📖 Intelligence Summary
Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗